v3.26.1
Condensed Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2025 [1] $ 843 $ 24,157 $ (49,204) $ (24,204)
Balance (in Shares) at Dec. 31, 2025 [1] 8,433,333      
Accretion for Class A ordinary shares subject to possible redemption to redemption value (9,792,813) (6,565,964) (16,358,777)
Sale of 5,000,000 Private Placement Warrants 5,000,000 5,000,000
Fair value of Public Warrants at issuance 4,216,667 4,216,667
Fair value of representative shares at issuance $ 19 745,699 745,718
Fair value of representative shares at issuance (in Shares) 189,750        
Allocated value of transaction costs to Class A shares (193,710) (193,710)
Net income 1,071,660 1,071,660
Balance at Mar. 31, 2026 $ 19 $ 843 (5,543,508) (5,542,646)
Balance (in Shares) at Mar. 31, 2026 189,750 8,433,333      
Balance at Dec. 31, 2025 [1] $ 843 24,157 (49,204) (24,204)
Balance (in Shares) at Dec. 31, 2025 [1] 8,433,333      
Net income         2,080,060
Balance at Jun. 30, 2026 $ 19 $ 843 (6,801,643) (6,800,781)
Balance (in Shares) at Jun. 30, 2026 189,750 8,433,333      
Balance at Mar. 31, 2026 $ 19 $ 843 (5,543,508) (5,542,646)
Balance (in Shares) at Mar. 31, 2026 189,750 8,433,333      
Accretion for Class A ordinary shares subject to possible redemption to redemption value (2,266,535) (2,266,535)
Net income 1,008,400 1,008,400
Balance at Jun. 30, 2026 $ 19 $ 843 $ (6,801,643) $ (6,800,781)
Balance (in Shares) at Jun. 30, 2026 189,750 8,433,333      
[1] Included up to 1,100,000 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the Underwriters (see Note 5). On March 12, 2026, the Underwriters exercised the over-allotment option in full, and the closing of the issuance and sale of the additional Units occurred on March 16, 2026. As such, on March 16, 2026, the 1,100,000 Class B ordinary shares are no longer subject to forfeiture.